Nodal maximum standardised uptake value improves PSMA ‐ PET / CT ‐based nodal staging in intermediate‐ and high‐risk prostate cancer

Key Points

• This research aims to evaluate the impact of nodal SUVmax on the efficacy of PSMA-PET/CT for nodal staging in prostate cancer.
• Assessed the positive predictive value (PPV) of PSMA-PET/CT using nodal SUVmax.
• Investigated integration of nodal SUVmax with clinical parameters.
• Recommended external validation in larger patient cohorts.
• Nodal SUVmax significantly improved the PPV of PSMA-PET for nodal staging.
• The integration of SUVmax with clinical parameters suggests enhanced decision-making.
• Findings indicate potential to better exclude high-volume nodal disease.